In vitro antibacterial efficacy of plants used by an Indian aboriginal tribe against pathogenic bacteria isolated from clinical samples
Abstract
To evaluate antibacterial efficacies of 21 medicinal plants used by an Indian aboriginal tribe against infectious diseases caused by bacteria isolated from clinical samples. Standard biochemical procedures were followed for identifying bacteria that were isolated from several clinical samples. All of the bacterial strains were subjected to antibiotic sensitivity tests by Kirby–Bauer's disc diffusion method. From antibiograms of isolated Gram-positive and Gram-negative bacteria, it was discernible that samples were multidrug resistant (MDR). The methanol leaf-extract of Solanum xanthocarpum was subjected to thin layer chromatography (TLC) for phytochemical analysis. Molecular docking of β-lactamase enzyme of Escherichia coli with phytochemicals of S. xanthocarpum was performed to locate effective compounds. The most effective 5 plants, which caused the size of the zone of inhibition to range from 21 to 27 mm, were Buchanania latifolia, Careya arborea, Ocimum tenuiflorum, Senna alata and S. xanthocarpum, for MDR bacteria. S. xanthocarpum had the lowest MIC value of 0.67 mg/ml and the lowest MBC value of 1.51 mg/ml against E. coli. In the TLC study, 9 spots of methanol leaf-extract of S. xanthocarpum were recorded with two solvent systems. The phytochemicals of S. xanthocarpum, solasodine and stigmasterol glucoside had the highest docking score values, −10.868 kcal/mol and −10.439 kcal/mol, respectively, against β-lactamase. This study could prove in vitro antimicrobial…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.